Diabetic kidney disease (DKD) is the first cause of end-stage kidney disease in patients with diabetes and its prevalence is increasing worldwide. It encompasses histological alterations that mainly affect the glomerular filtration unit, which include thickening of the basement membrane, mesangial cell proliferation, endothelial alteration, and podocyte injury. These morphological abnormalities further result in a persistent increase of urinary albumin-to-creatinine ratio and in a reduction of the estimated glomerular filtration rate. Several molecular and cellular mechanisms have been recognized, up to date, as major players in mediating such clinical and histological features and many more are being under investigation. This review summarizes the most recent advances in understanding cell death mechanisms, intracellular signaling pathways and molecular effectors that play a role in the onset and progression of diabetic kidney damage. Some of those molecular and cellular mechanisms have been already successfully targeted in preclinical models of DKD and, in some cases, strategies have been tested in clinical trials. Finally, this report sheds light on the relevance of novel pathways that may become therapeutic targets for future applications in DKD.
Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease / A. Petrazzuolo, G. Sabiu, E. Assi, A. Maestroni, I. Pastore, M.E. Lunati, L. Montefusco, C. Loretelli, G. Rossi, M. Ben Nasr, V. Usuelli, Y. Xie, H.B. Balasubramanian, M. Zocchi, B. El Essawy, J. Yang, F. D'Addio, P. Fiorina. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - 190:(2023 Apr). [Epub ahead of print] [10.1016/j.phrs.2023.106710]
Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease
A. PetrazzuoloPrimo
;G. SabiuSecondo
;E. Assi;A. Maestroni;I. Pastore;C. Loretelli;G. Rossi;M. Ben Nasr;V. Usuelli;H.B. Balasubramanian;M. Zocchi;F. D'Addio
Penultimo
;P. Fiorina
Ultimo
2023
Abstract
Diabetic kidney disease (DKD) is the first cause of end-stage kidney disease in patients with diabetes and its prevalence is increasing worldwide. It encompasses histological alterations that mainly affect the glomerular filtration unit, which include thickening of the basement membrane, mesangial cell proliferation, endothelial alteration, and podocyte injury. These morphological abnormalities further result in a persistent increase of urinary albumin-to-creatinine ratio and in a reduction of the estimated glomerular filtration rate. Several molecular and cellular mechanisms have been recognized, up to date, as major players in mediating such clinical and histological features and many more are being under investigation. This review summarizes the most recent advances in understanding cell death mechanisms, intracellular signaling pathways and molecular effectors that play a role in the onset and progression of diabetic kidney damage. Some of those molecular and cellular mechanisms have been already successfully targeted in preclinical models of DKD and, in some cases, strategies have been tested in clinical trials. Finally, this report sheds light on the relevance of novel pathways that may become therapeutic targets for future applications in DKD.File | Dimensione | Formato | |
---|---|---|---|
Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease.pdf
accesso aperto
Descrizione: Article
Tipologia:
Publisher's version/PDF
Dimensione
1.42 MB
Formato
Adobe PDF
|
1.42 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.